A prospective observational study of the mRNA-1273 and ChAdOx1 nCoV-19 vaccines in Asian patients with autoimmune rheumatic diseases under biologic and/or conventional immunosuppressant treatments.
Latest Information Update: 24 Nov 2022
At a glance
- Drugs AZD 1222 (Primary) ; Elasomeran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 24 Nov 2022 New trial record
- 01 Nov 2022 Results published in the Scandinavian Journal of Rheumatology